Cidara Therapeutics Inc (NASDAQ:CDTX) price is hovering lower on Tuesday, April 16, dropping -6.63% below its previous close.
A look at today’s price movement shows that the recent level at last check reads $0.82. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.48 and 52-week low of $0.59. The stock added 12.43% on its value in the past month.
Cidara Therapeutics Inc, which has a market valuation of $69.78 million. Analysts tracking CDTX have forecast the quarterly EPS to shrink by -0.1 per share this quarter, while the same analysts predict the annual EPS to hit -$0.31 for the year 2024 and up to -$0.58 for 2024. In this case, analysts estimate an annual EPS growth of 27.90% for the year and -87.10% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $11.54 million, with the likely lows of $6.7 million and highs of $14 million. The average estimate suggests sales growth for the quarter will likely rise by 12.90% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of $57.85 million for the company’s annual revenue in 2023. Per this projection, the revenue is forecast to grow -10.00% below that which the company brought in 2023.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with — upward and — downward reviews. On the technical perspective front, indicators give CDTX a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
The overview shows that CDTX’s price is at present -12.95% off the SMA20 and 0.13% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 43.81, with weekly volatility standing at 17.97%. The indicator jumps to 13.97% when calculated based on the past 30 days. Cidara Therapeutics Inc (NASDAQ:CDTX)’s beta value is holding at 1.03, while the average true range (ATR) indicator is currently reading 0.11.
An analysis of the Cidara Therapeutics Inc (NASDAQ:CDTX) stock in terms of its daily trading volume indicates that the 3-month average is 687.81K.
Current records show that the company has 90.62M in outstanding shares. The insiders’ percentage holdings are 9.96% of outstanding shares while the percentage share held by institutions stands at 29.71%. But the -3.02% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
